BRM:FRA
Bristol-Myers Squibb Co
53,82 €
arrow_upward
+1,60%(+0,85) 1d
20 d’oct., 15:47:57 GMT+2 · EUR
search
Tots els sÃmbols
| SÃmbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadÃstiques principals per a BRM...
Obre
52,36 €
Alt
53,82 €
Baix
52,36 €
Capitalització borsà ria
125,74Â kM
Volum mitjÃ
221,00
Volum
0,00
Alt 52 setmanes
60,64 €
Baix 52 setmanes
36,65 €
Nombre d'empleats
32Â k
Obre
52,36 €
Alt
53,82 €
Baix
52,36 €
Capitalització borsà ria
125,74Â kM
Volum mitjÃ
221,00
Volum
0,00
Alt 52 setmanes
60,64 €
Baix 52 setmanes
36,65 €
Nombre d'empleats
32Â k
NotÃcies
De fonts web i partners de notÃcies
24/7 Wall St.
·
fa 1 hora
Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%
TradingKey
·
fa 4 hores
Bristol-Myers Squibb Co Stock (BMY) Moved Up by 3.39% on Oct 20: Key Drivers Unveiled
MarketBeat
·
fa 8 hores
Bristol Myers Squibb Company (NYSE:BMY) Stock Has Average Target Price of $64.88 According to Analysts
Trefis
·
fa 10 hores
What Is Going On With Bristol Myers Squibb Stock?
Perfil
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Sobre Bristol-Myers Squibb Co
Conseller delegatChris Boerner
Empleats32,5Â k
Fundació1887
Seu principalNova York, Nova York, Estats Units d'Amèrica
Sector-
Lloc webbms.com